These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7589769)

  • 1. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
    Dağoğlu T; Ovali F; Samanci N; Bengisu E
    J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
    Onesimo R; Rizzo D; Ruggiero A; Valentini P
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immunoglobulins in neonatal Rhesus haemolytic disease.
    Greenough A
    BioDrugs; 2001; 15(8):533-41. PubMed ID: 11543694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-C haemolytic disease requiring intrauterine and exchange transfusion.
    Baker JW; Harrison KL; Harvey PJ
    Med J Aust; 1981 Sep; 2(6):296. PubMed ID: 6795430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.
    Ergaz Z; Arad I
    J Perinat Med; 1993; 21(3):183-7. PubMed ID: 8229608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
    Bowell P; Wainscoat JS; Peto TE; Gunson HH
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):219-29. PubMed ID: 5004392
    [No Abstract]   [Full Text] [Related]  

  • 20. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
    Keir AK; Dunn M; Callum J
    J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.